These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28894518)

  • 21. Quantification of methylated markers with a multiplex methylation-specific technology.
    Zou H; Allawi H; Cao X; Domanico M; Harrington J; Taylor WR; Yab T; Ahlquist DA; Lidgard G
    Clin Chem; 2012 Feb; 58(2):375-83. PubMed ID: 22194633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of Promoter Methylation Patterns of HOXA2, HOXA5, and HOXA6 and Its Clinicopathological Characteristics in Colorectal Cancer.
    Li D; Bai Y; Feng Z; Li W; Yang C; Guo Y; Lin C; Zhang Y; He Q; Hu G; Li X
    Front Oncol; 2019; 9():394. PubMed ID: 31165042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma.
    Kumar A; Gosipatala SB; Pandey A; Singh P
    Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
    Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
    Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.
    Baek YH; Chang E; Kim YJ; Kim BK; Sohn JH; Park DI
    Dis Colon Rectum; 2009 Aug; 52(8):1452-9; discussion 1459-63. PubMed ID: 19617759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development.
    Loh K; Chia JA; Greco S; Cozzi SJ; Buttenshaw RL; Bond CE; Simms LA; Pike T; Young JP; Jass JR; Spring KJ; Leggett BA; Whitehall VL
    Genes Chromosomes Cancer; 2008 Jun; 47(6):449-60. PubMed ID: 18311777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and Clinical Significance of DLC1 Gene Methylation in Serum DNA from Colorectal Cancer Patients.
    Wu PP; Zou JH; Tang RN; Yao Y; You CZ
    Chin J Cancer Res; 2011 Dec; 23(4):283-7. PubMed ID: 23359753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of BMP6 is associated with its methylation status in colorectal cancer tissue but lacks prognostic significance.
    Sangplod P; Kanngurn S; Boonpipattanapong T; Ruangrat P; Sangkhathat S
    Asian Pac J Cancer Prev; 2014; 15(17):7091-5. PubMed ID: 25227796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways.
    Wen J; Liu X; Qi Y; Niu F; Niu Z; Geng W; Zou Z; Huang R; Wang J; Zou H
    J Exp Clin Cancer Res; 2019 Oct; 38(1):428. PubMed ID: 31665064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
    Zou H; Yu B; Zhao R; Wang Z; Cang H; Li D; Feng G; Yi J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Dec; 36(7):499-501. PubMed ID: 12411153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation biomarkers in stool for early screening of colorectal cancer.
    Chen J; Sun H; Tang W; Zhou L; Xie X; Qu Z; Chen M; Wang S; Yang T; Dai Y; Wang Y; Gao T; Zhou Q; Song Z; Liao M; Liu W
    J Cancer; 2019; 10(21):5264-5271. PubMed ID: 31602277
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue.
    Levin TR; Corley DA; Jensen CD; Marks AR; Zhao WK; Zebrowski AM; Quinn VP; Browne LW; Taylor WR; Ahlquist DA; Lidgard GP; Berger BM
    Dig Dis Sci; 2017 Mar; 62(3):678-688. PubMed ID: 28044229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel bisulfite-microfluidic temperature gradient capillary electrophoresis platform for highly sensitive detection of gene promoter methylation.
    Zhang H; Shan L; Wang X; Ma Q; Fang J
    Biosens Bioelectron; 2013 Apr; 42():503-11. PubMed ID: 23246658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
    Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
    Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
    Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
    BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation assay for colorectal carcinoma.
    Chen JJ; Wang AQ; Chen QQ
    Cancer Biol Med; 2017 Feb; 14(1):42-49. PubMed ID: 28443202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review.
    Liang TJ; Wang HX; Zheng YY; Cao YQ; Wu X; Zhou X; Dong SX
    Oncotarget; 2017 Jul; 8(28):46468-46479. PubMed ID: 28515349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.